Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
Andrea Becerril‐Gaitan, Bryan F. Vaca‐Cartagena, Ana S. Ferrigno, Fernanda Mesa-Chávez, Tonatiuh Barrientos‐Gutiérrez, Marco Tagliamento, Matteo Lambertini, Cynthia Villarreal‐Garza
Topics & Concepts
MedicineVaccinationCoronavirusImmunogenicityDiseaseCoronavirus disease 2019 (COVID-19)CancerPopulationMeta-analysisImmunologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyInternal medicineInfectious disease (medical specialty)AntibodyEnvironmental healthSARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impactsLymphadenopathy Diagnosis and Analysis